The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
Mass spectrometry for detection of 4‐hydroxy‐trans‐2‐nonenal (HNE) adducts with peptides and proteins
Abstract
I. Introduction 282 A. 4‐Hydroxy‐trans‐2‐Nonenal (HNE): Biological Effects and Mechanism of Formation 282 B. HNE Reactivity and Reaction Mechanisms with Target Proteins 282 C. HNE: Pathological Implications 284 II. Analytical Approaches for Detection of HNE Adducts 285 A. Chemical Methods 285 B. Immunochemical Methods 286 C. Mass Spectrometry 287 III. Interaction of HNE with Peptides 287 A. GSH and Histidine‐Containing Peptides as HNE Detoxifying Agents 287 B. Synthetic and Biological Model Peptides 289 IV. Interaction of HNE with Proteins 291 A. Hemoproteins 291 B. Lipoproteins 293 C. Enzymes 294 1. Glucose‐6‐Phosphate Dehydrogenase (G6PDH) 295 2. Cathepsin B 295 3. Glyceraldehyde‐3‐Phosphate Dehydrogenase (GAPDH) 295 4. Cytochrome‐c Oxidase (CcO) 296 D. Other Proteins 299 1. Rhodopsin 299 2. Insulin 299 3. Epithelial Fatty Acid‐Binding Protein (E‐FABP) 300 V. Conclusions and Future Perspectives 300 Abbreviations 302 References 302 Despite the great technical advancement of mass spectrometry, this technique has contributed in a limited way to the discovery and quantitation of specific/precocious markers linked to free radical‐mediated diseases. Unsaturated aldehydes generated by free radical‐induced lipid peroxidation of polyunsaturated fatty acids, and in particular 4‐hydroxy‐trans‐2 nonenal (HNE), are involved in the onset and progression of many pathologies such as cardiovascular (atherosclerosis, long‐term complications of diabetes) and neurodegenerative diseases (Alzheimer's disease, Parkinson's disease, and cerebral ischemia). Most of the biological effects of HNE are attributed to the capacity of HNE to react with the nucleophilic sites of proteins and peptides (other than nucleic acids), to form covalently modified biomolecules that can disrupt important cellular functions and induce mutations. By considering the emerging role of HNE in several human diseases, an unequivocal analytical approach as mass spectrometry to detect/elucidate the structure of protein‐HNE adducts in biological matrices is strictly needed not only to understand the reaction mechanism of HNE, but also to gain a deeper insight into the pathological role of HNE. This with the aim to provide intermediate diagnostic biomarkers for human diseases. This review sheds focus on the “state‐of‐the‐art” of mass spectrometric applications in the field of HNE‐protein adducts characterization, starting from the fundamental early studies and discussing the different MS‐based approaches that can provide detailed information on the mechanistic aspects of HNE–protein interaction. In the last decade, the increases in the accessible mass ranges of modern instruments and advances in ionization methods have made possible a fundamental improvement in the analysis of protein–HNE adducts by mass spectrometry, and in particular by matrix‐assisted laser desorption/ionization (MALDI) and electrospray ionization (ESI) tandem mass spectrometry. The recent developments and uses of combined analytical approaches to detect and characterize the type/site of interaction have been highlighted, and several other aspects, including sample preparation methodologies, structure elucidation, and data analysis have also been considered. © 2004 Wiley Periodicals, Inc., Mass Spec Rev 23:281–305, 2004
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
4-Hydroxy-2-nonenal: a product and mediator of oxidative stress
Uchida, K. (2003) · Progress in Lipid Research · doi:10.1016/s0163-7827(03)00014-6 · Cited by 1,164
Benedetti, A., Comporti, M., & Esterbauer, H. (1980) · Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism · doi:10.1016/0005-2760(80)90209-x · Cited by 1,085
Immunohistochemical detection of 4-hydroxynonenal protein adducts in Parkinson disease.
Yoritaka, A., Hattori, N., Uchida, K., Tanaka, M., Stadtman, E. R., & Mizuno, Y. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.7.2696 · Cited by 981
Two Distinct Pathways of Formation of 4-Hydroxynonenal
Schneider, C., Tallman, K. A., Porter, N. A., & Brash, A. R. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m101821200 · Cited by 313
REQUENA, J. R., FU, M. X., AHMED, M. U., JENKINS, A. J., LYONS, T. J., BAYNES, J. W., & THORPE, S. R. (1997) · Biochemical Journal · doi:10.1042/bj3220317 · Cited by 293
Cited by
Kurutas, E. B. (2015) · Nutrition Journal · doi:10.1186/s12937-016-0186-5 · Cited by 2,152
Biomarkers of Oxidative Damage in Human Disease
Dalle-Donne, I., Rossi, R., Colombo, R., Giustarini, D., & Milzani, A. (2006) · Clinical Chemistry · doi:10.1373/clinchem.2005.061408 · Cited by 1,703
Negre‐Salvayre, A., Coatrieux, C., Ingueneau, C., & Salvayre, R. (2008) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0707395 · Cited by 641
Oxidative Stress and Covalent Modification of Protein with Bioactive Aldehydes
Grimsrud, P. A., Xie, H., Griffin, T. J., & Bernlohr, D. A. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.r700019200 · Cited by 572
Chemistry and biochemistry of lipid peroxidation products
Guéraud, F., Atalay, M., Bresgen, N., Cipak, A., Eckl, P. M., Huc, L., Jouanin, I., Siems, W., & Uchida, K. (2010) · Free Radical Research · doi:10.3109/10715762.2010.498477 · Cited by 552
Metadata
- Authors
- Carini, M., Aldini, G., & Facino, R. M.
- Venue
- Mass Spectrometry Reviews
- Publisher
- Wiley
- Published
- 2004-03-08
- Volume
- 23
- Issue
- 4
- Pages
- 281-305
- ISSN
- 0277-7037 (ISSN-L)
- 1098-2787
- OpenAlex
- W2138560564
- Cited by
- 177
- References
- 5
- FWCI
- 5.04
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.